Table 3 Hazard ratios (HR) of death in the first four weeks of treatment, Arba Minch Hospital, 2006
From: Predictors of early death in a cohort of Ethiopian patients treated with HAART
Factor | Crude HR(95%CI) | P-value | Adjusted HR (95%CI) | P-value |
|---|---|---|---|---|
WHO stage IV vs. II-III | 10.5 (2.1–52.4) | 0.004 | 9.2 (1.8–45.8) | 0.007 |
TLC<= 750 vs. >750/mcL | 5.2 (1.2–21.9) | 0.024 | 4.4 (1.05–18.5) | 0.043 |
HGB<= 10 vs. >10 g/dl | 3.5 (0.4–28.3) | 0.244 | -- | -- |
TLC<= 1200 vs. >1200/mcL | 3.4 (0.4–25.7) | 0.282 | -- | -- |
BMI<= 18.5 vs. >18.5 kg/m2 | 1.5 (0.3–9.3) | 0.629 | -- | -- |